推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Is pathological gambling in Parkinson's disease reduced by amantadine?

JY Lee, HJ Kim… - Annals of Neurology, 2011 - Wiley Online Library
Page 1. Is pathological gambling in Parkinson's disease reduced by amantadine? ...
treatment strategies remain very challenging. Thomas et al.3 recently showed that
PG can be reduced by amantadine administration in arandomized ...
Cited by 2 - Related articles - All 2 versions

P. 07 The role of amantadine in motor complications after deep brain stimulation for Parkinson's disease

RA Bosnell, R Mitchell, D Siddique… - Journal of Neurology, …, 2011 - jnnp.bmj.com
OMAS is rare affecting 1 in 10 million people per year. Symptoms include rapid, involuntary,
multidirectional conjugate eye move- ments, brief involuntary movements of muscles and
truncal/ appendicular cerebellar ataxia. The combination of its rarity and postulated ...

Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GNDF in astroglia

B Ossola, N Schendzielorz, SH Chen, GS Bird… - …, 2011 - Elsevier
Amantadine is commonly given to alleviate L-DOPA-induced dyskinesia of Parkinson's disease
(PD) patients. Animal and human evidence showed that amantadine may also exert neuroprotection
in several neurological disorders. Additionally, it is generally believed that this ...
All 2 versions

Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled …

VP Hoffmann, M Case… - The Journal of clinical …, 2011 - ncbi.nlm.nih.gov
OBJECTIVE: This 22-week, open-label study, conducted between November 2006 and September
2008 in a community setting, was designed to determine if weight gain during olanzapine treatment
can be prevented or mitigated with adjunctive treatment algorithms that include ...

Emergence and Phylogenetic Analysis of Amantadine-Resistant Influenza A Subtype H3N2 Viruses in Dublin, Ireland, over Six Seasons from 2003/2004 to 2008/2009

A Salter, B Ni Laoi… - Intervirology, 2011 - content.karger.com
Objectives: To determine the prevalence of amantadine-resistant influenza A viruses and perform
genetic analysis of isolates collected in Dublin during six seasons (2003/2004 to
2008/2009). Methods: Known mutations in the matrix 2 gene (M2) conferring amantadine ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451